Cobalamin and metabolite assays' sensitivities depend greatly on whether the tested patients have clinical abnormalities (95%-99% sensitivities) or not (< 70% for cobalamin, but data and criteria vary).[1][1],[2][2] In his report of massive diagnostic failures in even symptomatic cobalamin
No takes yet. Share an insight, caveat, or question.
Ralph Carmel (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: